Divi's Laboratories Limited – NSE:DIVISLAB.NS

Divi's Laboratories Limited stock price today

INR 4,651.25
-1229.80
-20.91%
Financial Health
0
1
2
3
4
5
6
7
8
9

Divi's Laboratories Limited stock price monthly change

+29.56%
month

Divi's Laboratories Limited stock price quarterly change

+29.56%
quarter

Divi's Laboratories Limited stock price yearly change

+51.41%
year

Divi's Laboratories Limited key metrics

Market Cap
 1.55T
Enterprise value
 1.56T
P/E
 85.17
EV/Sales
 18.12
EV/EBITDA
 53.51
Price/Sales
 18.12
Price/Book
 11.38
PEG ratio
 1.46
EPS
 60.26
Revenue
 78.45B
EBITDA
 24.65B
Income
 15.98B
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 21.29%
Oper. margin
 19.17%
Gross margin
 50.85%
EBIT margin
 19.17%
EBITDA margin
 31.42%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Divi's Laboratories Limited stock price history

Divi's Laboratories Limited stock forecast

Divi's Laboratories Limited financial statements

Profit Margin

Divi's Laboratories Limited (NSE:DIVISLAB.NS): Profit margin
Jun 2023 17.78B 3.56B 20.02%
Sep 2023 19.09B 3.48B 18.23%
Dec 2023 18.55B 3.63B 19.57%
Mar 2024 23.03B 5.31B 23.06%
DIVISLAB.NS income statement history

Divi's Laboratories Limited Financials Estimate

Divi's Laboratories Limited (NSE:DIVISLAB.NS): Analyst Estimates
2026 105.28B 25.64B 24.35%
2027 119.85B 30.03B 25.06%

  • Analysts Price target

  • Financials & Ratios estimates

Show more
0.51%
Yield TTM
Divi's Laboratories Limited (NSE:DIVISLAB.NS): Payout ratio
Payout ratio 0%
Divi's Laboratories Limited (NSE:DIVISLAB.NS): Dividend Yield
2016 2.44%
2017
2019 0.7%
2020 1.94%
2022 0.45%
DIVISLAB.NS dividends history

Debt to Assets

Divi's Laboratories Limited (NSE:DIVISLAB.NS): Debt to assets
Dec 2022 0 0
Sep 2023 142830000000 16.06B 11.24%
Dec 2023 0 0
Mar 2024 154700000000 18.99B 12.28%
DIVISLAB.NS balance sheet history

Cash Flow

Divi's Laboratories Limited (NSE:DIVISLAB.NS): Cash Flow
Mar 2023 1.74B 0 0
Jun 2023 1.86B 0 0
Sep 2023 1.9B 0 0
Dec 2023 1.9B 0 0
DIVISLAB.NS cash flow history

Divi's Laboratories Limited alternative data

Divi's Laboratories Limited
Employees

Divi's Laboratories Limited (NSE:DIVISLAB.NS): Employee count
Aug 2023 16,543
Sep 2023 8,433
Oct 2023 8,433
Nov 2023 8,433
Dec 2023 8,433
Jan 2024 8,433
Feb 2024 8,433
Mar 2024 8,433
Apr 2024 8,433
May 2024 8,433
Jun 2024 8,433
Jul 2024 8,433

Divi's Laboratories Limited other data

Divi's Laboratories Limited
Executives

Insider Compensation
Dr. Murali Krishna Prasad Divi M. Pharm, Ph.D. (1951) MD & Executive Director
 $808,400,000
Mr. Venkata Ramana Nimmagadda B.Sc.(Chem) (1958) Executive Director
 $414,900,000
Dr. Kiran Satchandra Divi B. Pharm., M.Pharm (1976) Chief Executive Officer & Whole-Time Director
 $282,200,000
Ms. Nilima Prasad Divi (1982) Whole-time Director & Director of Commercial
 $275,900,000
Mr. Madhusudana Rao Divi (1944) Director of Projects & Whole-Time Director
 $11,600,000

Frequently Asked Questions (FAQ)

  • What's the price of Divi's Laboratories Limited stock today?

    One share of Divi's Laboratories Limited stock can currently be purchased for approximately $4,651.25.

  • When is Divi's Laboratories Limited's next earnings date?

    Unfortunately, Divi's Laboratories Limited's (DIVISLAB.NS) next earnings date is currently unknown.

  • Does Divi's Laboratories Limited pay dividends?

    Yes, Divi's Laboratories Limited pays dividends and its trailing 12-month yield is 0.51% with 0% payout ratio. The last Divi's Laboratories Limited stock dividend of $0 was paid on 11 Sep 2025.

  • How much money does Divi's Laboratories Limited make?

    Divi's Laboratories Limited has a market capitalization of 1.55T and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 10.84% to 78.45B US dollars.

  • What is Divi's Laboratories Limited's stock symbol?

    Divi's Laboratories Limited is traded on the NSE under the ticker symbol "DIVISLAB.NS".

  • What is Divi's Laboratories Limited's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Divi's Laboratories Limited?

    Shares of Divi's Laboratories Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Divi's Laboratories Limited's key executives?

    Divi's Laboratories Limited's management team includes the following people:

    • Dr. Murali Krishna Prasad Divi M. Pharm, Ph.D. MD & Executive Director(age: 74, pay: $808,400,000)
    • Mr. Venkata Ramana Nimmagadda B.Sc.(Chem) Executive Director(age: 67, pay: $414,900,000)
    • Dr. Kiran Satchandra Divi B. Pharm., M.Pharm Chief Executive Officer & Whole-Time Director(age: 49, pay: $282,200,000)
    • Ms. Nilima Prasad Divi Whole-time Director & Director of Commercial(age: 43, pay: $275,900,000)
    • Mr. Madhusudana Rao Divi Director of Projects & Whole-Time Director(age: 81, pay: $11,600,000)

  • How many employees does Divi's Laboratories Limited have?

    As Jul 2024, Divi's Laboratories Limited employs 8,433 workers.

  • When Divi's Laboratories Limited went public?

    Divi's Laboratories Limited is publicly traded company for more then 22 years since IPO on 12 Mar 2003.

  • What is Divi's Laboratories Limited's official website?

    The official website for Divi's Laboratories Limited is divislabs.com.

  • How can i contact Divi's Laboratories Limited?

    Divi's Laboratories Limited can be reached via phone at +91 40 6696 6300.

Divi's Laboratories Limited company profile:

Divi's Laboratories Limited

divislabs.com
Exchange:

NSE

Full time employees:

9,741

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.

+91 40 6696 6300
Divi Towers
Hyderabad, 500032

:
ISIN: INE361B01024
CUSIP: Y2076F112